Aims and Scope
Clinical Colorectal Cancer is a peer-reviewed medical journal published by CIG Media Group (Cancer Information Group) from 2001 to 2010 and by Elsevier since 2011. It publishes original articles describing various aspects of clinical and translational research of gastrointestinal cancers. The journal is devoted to articles on detection, diagnosis, prevention, and treatment of colorectal, pancreatic, liver, and other gastrointestinal cancers. The main emphasis is on recent scientific developments in all areas related to gastrointestinal cancers. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
Key Metrics
7.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.87
5-Year SI
5-year SI
- N/A 2-year SI
- 0.85 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Oncology
SJR
- Q2 Oncology
- Q1 Gastroenterology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.37
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Colorectal cancer
- Bevacizumab
- Neuroendocrine tumors
- Overall survival
- Adjuvant
- Systematic review
- Chemoradiotherapy
- Multivariate analysis
- CpG Island Methylator Phenotype
- Primary tumor
- Oxaliplatin
- Clinical trial
- Toxicity
- Systemic therapy
- Cetuximab
- Progression-free survival
- Bone marrow
- Antitumor activity
- Locoregional disease
- Confidence interval
Journal Specifications
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Clinical Colorectal Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Triplet Chemotherapy in Patients With Metastatic Colorectal Cancer: Toward the Best Way to Safely Administer a Highly Active Regimen in Clinical Practice
- 1 Dec 12
- Clinical Colorectal Cancer
-
Full paper
The Therapeutic and Adverse Effects of Modified Radiation Fields for Patients With Rectal Cancer
- 1 Dec 12
- Clinical Colorectal Cancer
-
Full paper
Editorial Board
- 1 Dec 12
- Clinical Colorectal Cancer
-
Full paper
Liver-Directed Therapies: Does It Make Sense in the Current Therapeutic Strategy for Patients With Confined Liver Colorectal Metastases?
- 1 Sep 12
- Clinical Colorectal Cancer
-
Full paper
Metastatic Gastric Large Cell Neuroendocrine Carcinoma: A Case Report and Review of Literature
- 1 Sep 12
- Clinical Colorectal Cancer
-
Full paper
Survival Differences in Patients With Metastatic Colorectal Cancer and With Single Site Metastatic Disease at Initial Presentation: Results From South Australian Clinical Registry for Advanced Colorectal Cancer
- 3 Jul 12
- Clinical Colorectal Cancer
Scite analysis
Powered by scite_
1.5k articles received 20.7k citations see all
- 910 Supporting
- 19,183 Mentioning
- 160 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 1 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
49%
4 to 6 months
35%
7 to 9 months
10%
Above 9 months
6%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Clinical Colorectal Cancer been actively publishing?
Clinical Colorectal Cancer has been in operation since 2000 till date.
What is the publishing frequency of Clinical Colorectal Cancer ?
Clinical Colorectal Cancer published with a Quarterly frequency.
What is the eISSN & pISSN for Clinical Colorectal Cancer ?
For Clinical Colorectal Cancer,eISSN is 1938-0674 and pISSN is1533-0028.
What is Citescore for Clinical Colorectal Cancer ?
Citescore for Clinical Colorectal Cancer is 7.4.
What is SNIP score for Clinical Colorectal Cancer ?
SNIP score for Clinical Colorectal Cancer is 1.37.
What is the SJR for Clinical Colorectal Cancer ?
SJR for Clinical Colorectal Cancer is Q2.
Who is the publisher of Clinical Colorectal Cancer ?
CIG MEDIA GROUP, LP is the publisher of Clinical Colorectal Cancer.